Surprise Me!
Biocon’s Kiran Mazumdar Shaw On Who’ll Win The Battle Between ‘Innovators’ And Biosimilar Makers
2022-02-25
1
Dailymotion
Related Videos
Look forward to an IPO in next 18-24 months, says Biocon’s Kiran Mazumdar Shaw
Biocon's Mazumdar Shaw Says Firm On Track To Be Top Insulin Maker
Kiran Mazumdar Shaw of Biocon on biosimilar & business outlook
Q2WithBQ With Biocon's Kiran Mazumdar Shaw
Profit Insights | Biocon's Kiran Mazumdar Shaw Exclusive | NDTV Profit
Corporate tax cut is a much needed reform, says Biocon's Kiran Mazumdar Shaw
kiran-mazumdar-shaw-at-global-technology-summit
Q4 Review: Biocon's Kiran Mazumdar Shaw On Earnings & FY23 Projections
Kiran Mazumdar Shaw On Fighting and Recovering From COVID-19: ‘Dont Panic, Be Positive
Interview: Biocon's Chairman MD: Kiran Mazumdar-Shaw
